Skip to main content
dePort is a native bridge for assets that allows protocols to bridge tokens and create utility for their
synthetic representation (deTokens) on other chains.
dePort utilizes a lock-and-mint approach where the native token is locked/unlocked in a deBridgeGate smart contract on the native (source) chain
and its synthetic representation (deAsset) is minted/burnt in secondary (target) chains.
For each asset, under the native chain, we assume the unique blockchain where the token was originally created.
Secondary chains are blockchains supported by deBridge to which tokens can be transferred/bridged and where deAssets are minted.
Collateralization
Each of the tokens locked in the native chain have the associated wrapped asset on the target chains. By design, the protocol ensures that the
total supply of each deAsset that can be minted on secondary chains is always 1:1 backed by the asset collateral locked in the deBridgeGate
smart contract on the native chain. That provides more secure and reliable user experience and guarantees that the user will not face a liquidity
imbalance problem which has been encountered in other bridging solutions, where users face significant delays after they already locked liquidity
in a bridge.
Listing at deBridge
The deBridge protocol is universal and there are no listing requirements. Any arbitrary token can be bridged. If the token is bridged for the first
time, together with the validation transaction validators sign a unique deployId that is passed to the destination chain and contains the following
parameters:
- Native token smart contract address
- Native chain Id
- Token name
- Token symbol
- Decimals
The wrapped (deAsset) is deployed on the target chain automatically together with the first claim of the wrapped asset. Thus, no additional actions
are required from the user, listing is performed automatically by deBridge validators who sign a unique deployment ID. At deBridge, we care about
user experience and strive to minimize unnecessary actions to be performed by protocol users.